MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image Steve Edelson
Steve Edelson

Steve Edelson

Investors Relations Director at VERSANT VENTURES

Investor

Deal Bio

Total Deals5
Valued Deals4
Total Value£ 2.13 B
Avg. Deal Size£ 533 M

Market Context

Sort

08 Aug 2019|United States|Biotechnology
Bluerock Therapeutics
Bayer

Target: BLUEROCK THERAPEUTICS

Bidder: BAYER AG

4 Service Providers

1 Target | 2 Bidder | 1 Vendor

21 Dealmakers

2 Target | 16 Bidder | 3 Vendor

£ 493 M

Value

14 May 2020|Canada|Biotechnology
Northern Biologics
Boehringer Ingelheim

Target: NORTHERN BIOLOGICS

Bidder: BOEHRINGER INGELHEIM GMBH

4 Service Providers

2 Target | 1 Bidder | 1 Vendor

10 Dealmakers

6 Target | 3 Bidder | 1 Vendor

n/a

Value

05 Aug 2021|United States|Biotechnology
Vividion Therapeutics
Bayer

Target: VIVIDION THERAPEUTICS

Bidder: BAYER AG

13 Service Providers

3 Target | 3 Bidder | 7 Vendor

47 Dealmakers

22 Target | 5 Bidder | 21 Vendor

£ 1.44 B

Value

22 May 2024|Switzerland|Health Care Services
Sixpeaks Bio
Versant Ventures

Target: SIXPEAKS BIO AG

Bidder: VERSANT VENTURES

4 Service Providers

1 Target | 3 Bidder

11 Dealmakers

1 Target | 10 Bidder

£ 86 M

Value

22 Aug 2024|United States|Pharmaceuticals
Borealis Biosciences
Versant Ventures

Target: BOREALIS BIOSCIENCES

Bidder: VERSANT VENTURES

2 Service Providers

2 Bidder

3 Dealmakers

3 Bidder

£ 114 M

Value

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite